Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

Miller, E. J., SALISBURY, D. M., & Ramsay, M. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 483 · see citing works

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., & Miller, E. (2003) · BMJ · doi:10.1136/bmj.326.7385.365 · Cited by 409 · see citing works

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

Ramsay, M. E., Andrews, N. J., Kaczmarski, E. B., & Miller, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03594-7 · Cited by 337 · see citing works

Estimating<i>Haemophilus influenzae</i>Type b Vaccine Effectiveness in England and Wales by Use of the Screening Method

Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376997 · Cited by 172 · see citing works

Antibody Persistence and Immunological Memory at Age 4 Years after Meningococcal Group C Conjugate Vaccination in Children in the United Kingdom

Borrow, R., Goldblatt, D., Andrews, N. J., Southern, J., Ashton, L., Deane, S., Morris, R., Cartwright, K. A. V., & Miller, E. (2002) · The Journal of Infectious Diseases · doi:10.1086/344324 · Cited by 114 · see citing works

A guide to vaccinology: from basic principles to new developments

Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593 · see citing works

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978 · see citing works

B-cell responses to vaccination at the extremes of age

Siegrist, C.-A., & Aspinall, R. (2009) · Nature Reviews Immunology · doi:10.1038/nri2508 · Cited by 659 · see citing works

Immunisation against infectious disease

SALISBURY, D. M., Ramsay, M. E., & Noakes, K. (2006) · Stationery Office eBooks · Cited by 636 · see citing works

Bacterial meningitis in children

Sáez‐Llorens, X., & McCracken, G. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13693-8 · Cited by 535 · see citing works

Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines

Pollard, A. J., Perrett, K. P., & Beverley, P. C. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2494 · Cited by 485 · see citing works

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527401 · Cited by 442 · see citing works

Neisseria meningitidis: Biology, Microbiology, and Epidemiology

Rouphael, N., & Stephens, D. S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-346-2_1 · Cited by 435 · see citing works

Meningococcal surrogates of protection?serum bactericidal antibody activity

Borrow, R., Balmer, P., & Miller, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.051 · Cited by 414 · see citing works

APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells

Belnoue, E., Pihlgren, M., McGaha, T. L., Tougne, C., Rochat, A., Bossen, C., Schneider, P., Huard, B., Lambert, P., & Siegrist, C. (2008) · Blood · doi:10.1182/blood-2007-09-110858 · Cited by 365 · see citing works

Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens

Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322 · see citing works

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

Read, R. C., Baxter, D. N., Chadwick, D., Faust, S. N., Finn, A. H. R., Gordon, S. B., Heath, P. T., Lewis, D. J., Pollard, A. J., Turner, D. P. J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60842-4 · Cited by 282 · see citing works

Protein carriers of conjugate vaccines: Characteristics, development and clinical trials

Pichichero, M. E. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26109 · Cited by 263 · see citing works

Advances in the Development of Vaccines againstNeisseria meningitidis

Tan, L., Carlone, G. M., & Borrow, R. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906357 · Cited by 233 · see citing works

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit

Gray, S. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46288-0 · Cited by 221 · see citing works

Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants

Snape, M. D., Perrett, K. P., Ford, K. J., John, T. M., Pace, D., Yu, L., Langley, J. M., McNeil, S., Dull, P. M., Ceddia, F., et al. (2008) · JAMA · doi:10.1001/jama.2007.29-c · Cited by 215 · see citing works

Vaccine immunology

Siegrist, C. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50006-4 · Cited by 215 · see citing works

Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity

Campbell, H. J., Andrews, N. J., Borrow, R., Trotter, C. L., & Miller, E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00529-09 · Cited by 213 · see citing works

Bacterial Meningitis in Children

Chávez‐Bueno, S., & McCracken, G. H. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.02.011 · Cited by 204 · see citing works

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs

Trotter, C. L., & Maiden, M. C. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.48 · Cited by 203 · see citing works

Conquering the Meningococcus

Stephens, D. S. (2007) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00051.x · Cited by 203 · see citing works

Neisseria meningitidis group B correlates of protection and assay standardization—International Meeting Report Emory University, Atlanta, Georgia, United States, 16–17 March 2005

Borrow, R., Carlone, G. M., Rosenstein, N. E., Blake, M., Feavers, I. M., Martin, D., Zollinger, W. D., Robbins, J., Aaberge, I. S., Granoff, D. M., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.091 · Cited by 197 · see citing works

Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup BNeisseria meningitidis

Murphy, E., Andrew, L., Lee, K., Dilts, D. A., Nuñez, L., Fink, P. S., Ambrose, K. D., Borrow, R., Findlow, J., Taha, M., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600141 · Cited by 196 · see citing works

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

Frasch, C. E., Borrow, R., & Donnelly, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.065 · Cited by 190 · see citing works

Review of Meningococcal Group B Vaccines

Granoff, D. M. (2010) · Clinical Infectious Diseases · doi:10.1086/648966 · Cited by 189 · see citing works

Clinicians’ gut feeling about serious infections in children: observational study.

Van den Bruel, A., Thompson, M., Buntinx, F., & Mant, D. (2012) · BMJ · doi:10.1136/bmj.e6144 · Cited by 183 · see citing works

Can successful vaccines teach us how to induce efficient protective immune responses?

Lambert, P., Liu, M., & Siegrist, C. (2005) · Nature Medicine · doi:10.1038/nm1216 · Cited by 187 · see citing works

The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014

Whittaker, R., Dias, J. G., Ramliden, M., Ködmön, C., Economopoulou, A., Beer, N., Pastore Celentano, L., Kanitz, E., Richter, L., Mattheus, W., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.007 · Cited by 179 · see citing works

Prospects for Vaccine Prevention of Meningococcal Infection

Harrison, L. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.142-164.2006 · Cited by 178 · see citing works

Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination

Trotter, C. L., Gay, N. J., & Edmunds, W. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi160 · Cited by 176 · see citing works

Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low‐ and middle‐income countries

Cutts, F. T., & Hanson, M. (2016) · Tropical Medicine & International Health · doi:10.1111/tmi.12737 · Cited by 176 · see citing works

Meningococcal carriage in the African meningitis belt

Trotter, C. L., & Greenwood, B. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70288-8 · Cited by 174 · see citing works

Meningococcal polysaccharide–protein conjugate vaccines

Snape, M. D., & Pollard, A. J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01251-4 · Cited by 174 · see citing works

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain

Larrauri, A., Cano, R., García, M. J. S., & de Mateo, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.045 · Cited by 171 · see citing works

Meningococcal C conjugate vaccine: the experience in England and Wales

Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168 · see citing works

Outer membrane vesicles from group B Neisseria meningitidis Δgna33 mutant: Proteomic and immunological comparison with detergent‐derived outer membrane vesicles

Ferrari, G., Garaguso, I., Adu‐Bobie, J., Doro, F., Taddei, A. R., Biolchi, A., Brunelli, B., Giuliani, M. M., Pizza, M., Norais, N., et al. (2006) · PROTEOMICS · doi:10.1002/pmic.200500164 · Cited by 168 · see citing works

Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS)

Boeddha, N. P., Schlapbach, L. J., Driessen, G. J. A., Herberg, J. A., Calle, I. R., Cebey‐López, M., Klobassa, D. S., Philipsen, R. L. A., de Groot, R., Inwald, D. P., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2052-7 · Cited by 162 · see citing works

Global Epidemiology of Meningococcal Disease and Vaccine Efficacy

Pollard, A. J. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000147642.85129.05 · Cited by 161 · see citing works

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines

Trotter, C. L., & Ramsay, M. E. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00053.x · Cited by 159 · see citing works

The Meningitis Vaccine Project

LaForce, F. M., Konde, K., Viviani, S., & Préziosi, M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.049 · Cited by 158 · see citing works

Safety, Immunogenicity, and Immune Memory of a Novel Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MCV-4) in Healthy Adolescents

KEYSERLING, H. L., Papa, T., Koranyi, K., Ryall, R., Bassily, E. L., Bybel, M. J., Sullivan, K., Gilmet, G., & Reinhardt, A. (2005) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.159.10.907 · Cited by 155 · see citing works

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution

LaForce, F. M., Ravenscroft, N., Djingarey, M. H., & Viviani, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.062 · Cited by 150 · see citing works

A surveillance network for meningococcal disease in Europe

Trotter, C. L., Chandra, M., Cano, R., Larrauri, A., Ramsay, M. E., Brehony, C., Jolley, K. A., Maiden, M. C. J., Heuberger, S., & Frosch, M. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00060.x · Cited by 149 · see citing works

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix™

Prymula, R., & Schuerman, L. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.113 · Cited by 146 · see citing works

Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom

Auckland, C., Gray, S., Borrow, R., Andrews, N. J., Goldblatt, D., Ramsay, M. E., & Miller, E. (2006) · The Journal of Infectious Diseases · doi:10.1086/509619 · Cited by 143 · see citing works

Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study

Christensen, H., Trotter, C. L., Hickman, M., & Edmunds, W. J. (2014) · BMJ · doi:10.1136/bmj.g5725 · Cited by 142 · see citing works

Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

Trotter, C. L., McVernon, J., Ramsay, M. E., Whitney, C. G., Mulholland, K., Goldblatt, D., Hombach, J., & Kiény, M.-P. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.073 · Cited by 140 · see citing works

Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact

Christensen, H., Hickman, M., Edmunds, W. J., & Trotter, C. L. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.034 · Cited by 130 · see citing works

Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections

Sprong, T. (2006) · Blood · doi:10.1182/blood-2005-07-2820 · Cited by 133 · see citing works

Epidemiological Profile of Meningococcal Disease in the United States

Harrison, L. H. (2010) · Clinical Infectious Diseases · doi:10.1086/648963 · Cited by 134 · see citing works

PROTECTION FROM ROUTINE VACCINATION AT THE AGE OF 14 MONTHS WITH MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN THE NETHERLANDS

de Greeff, S. C., de Melker, H. E., Spanjaard, L., Schouls, L. M., & ENDE, A. V. D. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000195594.41449.c6 · Cited by 130 · see citing works

Cost-Effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States

Shepard, C. W., Ortega‐Sanchez, I. R., Scott, R. D., Rosenstein, N. E., & and the ABCs Team (2005) · PEDIATRICS · doi:10.1542/peds.2004-2514 · Cited by 124 · see citing works

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

Snape, M. D., Kelly, D. F., Lewis, S. C., Banner, C., Kibwana, L., Moore, C. E., Diggle, L., John, T. M., Yu, L., Borrow, R., et al. (2008) · BMJ · doi:10.1136/bmj.39563.545255.ae · Cited by 123 · see citing works

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

Borrow, R., Andrews, N. J., Findlow, H., Waight, P., Southern, J., Crowley-Luke, A., Stapley, L., England, A., Findlow, J., & Miller, E. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00384-09 · Cited by 115 · see citing works

Multicenter Surveillance of Invasive Meningococcal Infections in Children

Kaplan, S. L., Schutze, G. E., Leake, J. A. D., Barson, W. J., Halasa, N., Byington, C. L., Woods, C. R., Tan, T. Q., Hoffman, J. A., Wald, E. R., et al. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0281 · Cited by 113 · see citing works

The Magnitude of the Antibody and Memory B Cell Responses during Priming with a Protein-Polysaccharide Conjugate Vaccine in Human Infants Is Associated with the Persistence of Antibody and the Intensity of Booster Response

Rohner, G. B., Snape, M. D., Kelly, D. F., John, T. M., Morant, A., Yu, L., Borkowski, A., Ceddia, F., Borrow, R., Siegrist, C., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2165 · Cited by 114 · see citing works

Immunological Memory: The Role of B Cells in Long-term Protection Against Invasive Bacterial Pathogens

Kelly, D. F., Pollard, A. J., & Moxon, E. R. (2005) · JAMA · doi:10.1001/jama.294.23.3019 · Cited by 113 · see citing works

Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines

Sun, X., Stefanetti, G., Berti, F., & Kasper, D. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816401115 · Cited by 112 · see citing works

Overview of the development and current use of CRM197 conjugate vaccines for pediatric use

Shinefield, H. R. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.072 · Cited by 112 · see citing works

British HIV Association guidelines for immunization of HIV‐infected adults 2008

Geretti, A. M. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00637.x · Cited by 110 · see citing works

Immunisation handbook 2006

Blackmore, T., Buchan, G. S., Grant, C. C., Grimwood, K., LENNON, D. R., Murdoch, D. R., Pierce, J., Reid, S., & Roberts, A. (2006) · Cited by 108 · see citing works

From Pasteur to genomics: progress and challenges in infectious diseases

Rappuoli, R. (2004) · Nature Medicine · doi:10.1038/nm1129 · Cited by 111 · see citing works

Timeliness of childhood immunisation in Australia

Hull, B. P., & McIntyre, P. B. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.049 · Cited by 110 · see citing works

A Prospective Study of the Effectiveness of the New Zealand Meningococcal B Vaccine

Kelly, C., Arnold, R., Galloway, Y., & O'Hallahan, J. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm147 · Cited by 110 · see citing works

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells

Kelly, D. F., Snape, M. D., Clutterbuck, E., Green, S., Snowden, C., Diggle, L., Yu, L., Borkowski, A., Moxon, E. R., & Pollard, A. J. (2006) · Blood · doi:10.1182/blood-2006-01-009282 · Cited by 107 · see citing works

Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents

Jackson, L. A., Baxter, R. P., Reisinger, K. S., Karsten, A., Shah, J., Bedell, L., Dull, P. M., & the V59P13 Study Group (2009) · Clinical Infectious Diseases · doi:10.1086/599117 · Cited by 107 · see citing works

Immunisation of premature infants

Bonhoeffer, J., Siegrist, C., & Heath, P. T. (2006) · Archives of Disease in Childhood · doi:10.1136/adc.2005.086306 · Cited by 106 · see citing works

Booster Vaccinations: Can Immunologic Memory Outpace Disease Pathogenesis?

Pichichero, M. E. (2009) · PEDIATRICS · doi:10.1542/peds.2008-3645 · Cited by 101 · see citing works

Effectiveness of a Mass Immunization Campaign Using Serogroup C Meningococcal Conjugate Vaccine

Wals, P. D. (2004) · JAMA · doi:10.1001/jama.292.20.2491 · Cited by 101 · see citing works

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease

Melegaro, A., Choi, Y. H., George, R. C., Edmunds, W. J., Miller, E., & Gay, N. J. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-90 · Cited by 99 · see citing works

Immune responses to polysaccharides: Lessons from humans and mice

González‐Fernández, Á., Faro, J., & Fernández, C. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.11.042 · Cited by 98 · see citing works

Lack of Serum Bactericidal Activity in Preschool Children Two Years After a Single Dose of Serogroup C Meningococcal Polysaccharide-Protein Conjugate Vaccine

Snape, M. D., Kelly, D. F., Green, B., Moxon, E. R., Borrow, R., & Pollard, A. J. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000151029.58752.27 · Cited by 98 · see citing works

Emergence of Endemic Serogroup W135 Meningococcal Disease Associated with a High Mortality Rate in South Africa

von Gottberg, A., du Plessis, M., Cohen, C., Prentice, E., Schrag, S. J., de Gouveia, L., Coulson, G., de Jong, G., Klugman, K. P., & Group for Enteric, R. A. M. D. S. I. S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/525260 · Cited by 98 · see citing works

Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years

Østergaard, L. J., Lebacq, E., POOLMAN, J. T., Maechler, G., & Boutriau, D. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.075 · Cited by 97 · see citing works

Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine

LaForce, F. M., & Okwo‐Bele, J. (2011) · Health Affairs · doi:10.1377/hlthaff.2011.0328 · Cited by 97 · see citing works

Reduced Ability of Neonatal and Early-Life Bone Marrow Stromal Cells to Support Plasmablast Survival

Pihlgren, M., Friedli, M., Tougne, C., Rochat, A.-F., Lambert, P.-H., & Siegrist, C.-A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.165 · Cited by 94 · see citing works

Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention

Sáfadi, M. A. P., & Cintra, O. A. L. (2010) · Neurological Research · doi:10.1179/016164110x12644252260754 · Cited by 93 · see citing works

Neonatal and Infantile Immune Responses to Encapsulated Bacteria and Conjugate Vaccines

Klouwenberg, P. M. C. K., & Bont, L. (2008) · Clinical and Developmental Immunology · doi:10.1155/2008/628963 · Cited by 89 · see citing works

Reconsideration of the Use of Meningococcal Polysaccharide Vaccine

Granoff, D. M., & Pollard, A. J. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3180cc2c25 · Cited by 89 · see citing works

Effectiveness of meningococcal serogroup C vaccine programmes

Borrow, R., Abad, R., Trotter, C., van der Klis, F. R. M., & Vazquez, J. A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.083 · Cited by 88 · see citing works

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose

Snape, M. D., Saroey, P., John, T. M., Robinson, H., Kelly, S., Gossger, N., Yu, L., Wang, H., Toneatto, D., Dull, P. M., et al. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.130257 · Cited by 85 · see citing works

Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary‐School Children in 1999–2000 and Response to a Booster: A Phase 4 Clinical Trial

Perrett, K. P., Winter, A. P., Kibwana, E., Jin, C., John, T. M., Yu, L., Borrow, R., Curtis, N. C., & Pollard, A. J. (2010) · Clinical Infectious Diseases · doi:10.1086/652765 · Cited by 83 · see citing works

Serogroup C Meningococcal Glycoconjugate Vaccine in Adolescents: Persistence of Bactericidal Antibodies and Kinetics of the Immune Response to a Booster Vaccine More Than 3 Years after Immunization

Snape, M. D., Kelly, D. F., Salt, P., Green, S., Snowden, C., Diggle, L., Borkowski, A., Yu, L., Moxon, E. R., & Pollard, A. J. (2006) · Clinical Infectious Diseases · doi:10.1086/508776 · Cited by 85 · see citing works

Vaccine immunology

Siegrist, C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00004-5 · Cited by 86 · see citing works

Meningococcal vaccines

Granoff, D. M., Harrison, L. H., & Borrow, R. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50023-4 · Cited by 84 · see citing works

A generic mechanism inNeisseria meningitidisfor enhanced resistance against bactericidal antibodies

Uría, M. J., Zhang, Q., Li, Y.-W., Chan, A., Exley, R. M., Gollan, B., Chan, H., Feavers, I. M., Yarwood, A., Abad, R., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072577 · Cited by 84 · see citing works

Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine

Cohn, A. C., MacNeil, J. R., Harrison, L. H., Lynfield, R., Reingold, A. L., Schaffner, W., Zell, E. R., Plikaytis, B. D., Wang, X., Messonnier, N. E., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2016-2193 · Cited by 83 · see citing works

Regulation of capsule inNeisseria meningitidis

Tzeng, Y., Thomas, J. D., & Stephens, D. S. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1022507 · Cited by 81 · see citing works

Two Decades of Experience With the Haemophilus influenzae Serotype b Conjugate Vaccine in the United Kingdom

Ladhani, S. N. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.027 · Cited by 79 · see citing works

Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine

de Voer, R. M., Mollema, L., Schepp, R. M., de Greeff, S. C., van Gageldonk, P. G. M., de Melker, H. E., Sanders, E. A. M., Berbers, G. A. M., & van der Klis, F. R. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012144 · Cited by 80 · see citing works

A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children

Knuf, M., Kieninger‐Baum, D., Habermehl, P., Muttonen, P., Maurer, H., Vink, P., POOLMAN, J. T., & Boutriau, D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.064 · Cited by 79 · see citing works

Invasive Meningococcal Disease in the 21st Century—An Update for the Clinician

Dwilow, R., & Fanella, S. T. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0524-6 · Cited by 79 · see citing works

Carrier priming or suppression: Understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines

Pobre, K., Tashani, M., Ridda, I., Rashid, H., Wong, M., & Booy, R. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.047 · Cited by 76 · see citing works

The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada

Bettinger, J. A., Scheifele, D. W., Saux, N. L., Halperin, S. A., Vaudry, W., & Tsang, R. S. W. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819040e7 · Cited by 76 · see citing works

Immunogenicity and Safety of a Combination Pneumococcal-Meningococcal Vaccine in Infants

Buttery, J. P., Riddell, A., McVernon, J., Chantler, T., Lane, L., Bowen‐Morris, J., Diggle, L., Morris, R., Harnden, A., Lockhart, S. P., et al. (2005) · JAMA · doi:10.1001/jama.293.14.1751 · Cited by 75 · see citing works

Antibody Persistence 3 Years after Immunization of Adolescents with Quadrivalent Meningococcal Conjugate Vaccine

Vu, D. M., Welsch, J. A., Zuno‐Mitchell, P., Cruz, J. V. D., & Granoff, D. M. (2006) · The Journal of Infectious Diseases · doi:10.1086/500512 · Cited by 74 · see citing works

Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients

(2005) · PEDIATRICS · doi:10.1542/peds.2005-1314 · Cited by 74 · see citing works

Vaccine Immunology

Siegrist, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00002-x · Cited by 75 · see citing works

Glycoconjugate vaccines: an update

Vella, M., & Pace, D. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.993375 · Cited by 73 · see citing works

Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age

Kitchin, N. R. E., Southern, J., Morris, R., Hemme, F., Thomas, S., Watson, M. W., Cartwright, K. A. V., & Miller, E. (2006) · Archives of Disease in Childhood · doi:10.1136/adc.2005.076109 · Cited by 73 · see citing works

Updated post-licensure surveillance of meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlate of protection and modelling predictions of the duration of herd immunity

Campbell, H., Andrews, N., Borrow, R., Trotter, C., & Miller, E. (2010) · Bristol Research (University of Bristol)

Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity

Campbell, H. J., Andrews, N. J., Borrow, R., Trotter, C. L., & Miller, E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00529-09 · Cited by 213 · see citing works

Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological

(2010)

Long-term protection in children with meningococcal C conjugate vaccination: lessons learned

Borrow, R., & Miller, E. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.6.851 · Cited by 58 · see citing works

Meningococcal C conjugate vaccine: the experience in England and Wales

Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168 · see citing works